References
- TorchilinVPTargeted pharmaceutical nanocarriers for cancer therapy and imagingAAPS J200792E128E14717614355
- ArachchigeMCReshetnyakYKAndreevOAAdvanced targeted nanomedicineJ Biotechnol2015202889725615945
- PetreCEDittmerDPLiposomal daunorubicin as treatment for Kaposi’s sarcomaInt J Nanomedicine20072327728818019828
- CaminadeA-MTurrinC-ODendrimers for drug deliveryJ Mater Chem B201422640554066
- MadaanKKumarSPooniaNLatherVPanditaDDendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issuesJ Pharm Bioallied Sci20146313915025035633
- OwensDErPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
- OhNParkJHEndocytosis and exocytosis of nanoparticles in mammalian cellsInt J Nanomedicine20149Suppl 1516324872703
- JonesSWRobertsRARobbinsGRNanoparticle clearance is governed by Th1/Th2 immunity and strain backgroundJ Clin Invest201312373061307323778144
- LiSDHuangLStealth nanoparticles: high density but sheddable PEG is a key for tumor targetingJ Control Release2010145317818120338200
- Allard-VannierECohen-JonathanSGautierJPegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivoEur J Pharm Biopharm201281349850522510695
- KreuterJRamgePPetrovVDirect evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticlesPharm Res200320340941612669961
- KurakhmaevaKBDjindjikhashviliIAPetrovVEBrain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticlesJ Drug Target200917856457419694610
- LinYPanYShiYHuangXJiaNJiangJYDelivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brainNanotechnology2012231616510122460562
- KreuterJNanoparticulate systems for brain delivery of drugsAdv Drug Deliv Rev2001471658111251246
- MulikRSMonkkonenJJuvonenROMahadikKRParadkarARApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cellsInt J Pharm20124371–2294122890189
- JoDHKimJHLeeTGKimJHSize, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseasesNanomedicine20151171603161125989200
- WalczykDBombelliFBMonopoliMPLynchIDawsonKAWhat the cell “sees” in bionanoscienceJ Am Chem Soc2010132165761576820356039
- LynchIDawsonKAProtein-nanoparticle interactionsNano Today200831–24047
- MahmoudiMLynchIEjtehadiMRMonopoliMPBombelliFBLaurentSProtein-nanoparticle interactions: opportunities and challengesChem Rev201111195610563721688848
- MonopoliMPWalczykDCampbellAPhysical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201113382525253421288025
- ZanganehSSpitlerRErfanzadehMAlkilanyAMMahmoudiMProtein corona: Opportunities and challengesInt J Biochem Cell Biol20167514314726783938
- ChengXTianXWuAProtein corona influences cellular uptake of gold nanoparticles by phagocytic and nonphagocytic cells in a size-dependent mannerACS Appl Mater Interfaces2015737205682057526364560
- RitzSSchottlerSKotmanNProtein corona of nanoparticles: distinct proteins regulate the cellular uptakeBiomacromolecules20151641311132125794196
- SalvatiAPitekASMonopoliMPTransferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surfaceNature Nanotechnol20138213714323334168
- MirshafieeVMahmoudiMLouKChengJKraftMLProtein corona significantly reduces active targeting yieldChem Commun2013492525572559
- GuoYWangLLvPZhangPTransferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancerOncol Lett2015931065107225663858
- KainthanRKJanzenJLevinEDevineDVBrooksDEBiocompatibility testing of branched and linear polyglycidolBiomacromolecules20067370370916529404
- DerneddeJRauschAWeinhartMDendritic polyglycerol sulfates as multivalent inhibitors of inflammationProc Natl Acad Sci U S A201010746196791968421041668
- KhandareJCalderonMDagiaNMHaagRMultifunctional dendritic polymers in nanomedicine: opportunities and challengesChem Soc Rev20124172824284822158998
- WeinhartMGrogerDEndersSThe role of dimension in multivalent binding events: structure-activity relationship of dendritic polyglycerol sulfate binding to L-selectin in correlation with size and surface charge densityMacromol Biosci20111181088109821648090
- WeinhartMGrogerDEndersSDerneddeJHaagRSynthesis of dendritic polyglycerol anions and their efficiency toward L-selectin inhibitionBiomacromolecules20111272502251121598905
- VonnemannJLieseSKuehneCSize dependence of steric shielding and multivalency effects for globular binding inhibitorsJ Am Chem Soc201513772572257925623606
- LouXWangCHeLCore-shell Au nanoparticle formation with DNA-polymer hybrid coatings using aqueous ATRPBiomacromolecules2007851385139017465524
- ZieglerCEychmüllerASeeded growth synthesis of uniform gold nanoparticles with diameters of 15−300 nmJ Phys Chem C20111151145024506
- VonnemannJSiebenCWolffCVirus inhibition induced by polyvalent nanoparticles of different sizesNanoscale2014642353256024430614
- GrogerDKerschnitzkiMWeinhartMSelectivity in bone targeting with multivalent dendritic polyanion dye conjugatesAdv Healthcare Mater201433375385
- RabilloudTStrubJ-MLucheSGirardetJvan DorsselaerALunardiJRuthenium II tris (bathophenanthroline disulfonate), a powerful fluorescent stain for detection of proteins in gel with minimal interference in subsequent mass spectrometry analysisProteome200011114
- VonnemannJBeziereNBottcherCPolyglycerolsulfate functionalized gold nanorods as optoacoustic signal nanoamplifiers for in vivo bioimaging of rheumatoid arthritisTheranostics20144662964124723984
- WalkeyCDChanWCUnderstanding and controlling the interaction of nanomaterials with proteins in a physiological environmentChem Soc Rev20124172780279922086677
- Le RoyCWranaJLClathrin- and non-clathrin-mediated endocytic regulation of cell signallingNat Rev Mol Cell Biol20056211212615687999
- WangLHRothbergKGAndersonRGMis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formationJ Cell Biol19931235110711178245121
- RoachPFarrarDPerryCCSurface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistryJ Am Chem Soc2006128123939394516551101
- ShannahanJHLaiXKePCPodilaRBrownJMWitzmannFASilver nanoparticle protein corona composition in cell culture mediaPLoS One201389e7400124040142
- SakulkhuUMahmoudiMMauriziLSalaklangJHofmannHProtein corona composition of superparamagnetic iron oxide nanoparticles with various physicochemical properties and coatingsSci Rep20144502024846348
- TenzerSDocterDRosfaSNanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysisACS Nano2011597155716721866933
- McMahonHTBoucrotEMolecular mechanism and physiological functions of clathrin-mediated endocytosisNat Rev Mol Cell Biol201112851753321779028
- PlowEFHaasTAZhangLLoftusJSmithJWLigand binding to integrinsJ Biol Chem200027529217852178810801897
- RuoslahtiERGD and other recognition sequences for integrinsAnnu Rev Cell Dev Biol1996126977158970741
- CampbellIDHumphriesMJIntegrin structure, activation, and interactionsCold Spring Harb Perspect Biol201133a00499421421922
- EmsleyJKnightCGFarndaleRWBarnesMJLiddingtonRCStructural basis of collagen recognition by integrin alpha2beta1Cell20001011475610778855
- ArosioDCasagrandeCAdvancement in integrin facilitated drug deliveryAdv Drug Deliv Rev20169711114326686830
- RajASarafPJavaliNMLiXJastiBBinding and uptake of novel RGD micelles to the alphavbeta3 integrin receptor for targeted drug deliveryJ Drug Target201422651852724611965
- LahtiMHeinoJKapylaJLeukocyte integrins alphaLbeta2, alphaM-beta2 and alphaXbeta2 as collagen receptors – receptor activation and recognition of GFOGER motifInt J Biochem Cell Biol20134571204121123542015
- HortonMAThe alpha v beta 3 integrin “vitronectin receptor”Int J Biochem Cell Biol19972957217259251239
- PytelaRPierschbacherMDRuoslahtiEA 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectinProc Natl Acad Sci U S A19858217576657702412224
- LiRLuoMRenMVitronectin regulation of vascular endothelial growth factor-mediated angiogenesisJ Vasc Res201451211011724603119
- TedjaRLimMAmalRMarquisCEffects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell linesACS Nano2012654083409322515565
- RitzSSchöttlerSKotmanNProtein corona of nanoparticles: distinct proteins regulate cellular uptakeBiomacromolecules2015161311132125794196